Related Experiment Videos
Correlates of change in postmenopausal estrogen use in a population-based study
American Journal of Epidemiology
|August 1, 1986
Summary
Concerns about endometrial cancer significantly reduced postmenopausal estrogen use. The presence of a uterus was the primary factor influencing discontinuation or initiation of hormone therapy.
Area of Science:
- Reproductive Health
- Endocrinology
- Epidemiology
Background:
- Postmenopausal estrogen use declined sharply in the late 1970s, potentially due to fears of an endometrial cancer link.
- Observational studies on hormone therapy require understanding factors influencing its use to evaluate health outcomes accurately.
Purpose of the Study:
- To identify predictors of changes in postmenopausal estrogen use between 1974-1981.
- To determine if characteristics differed between women initiating postmenopausal estrogen use and those who did not.
Main Methods:
- A cohort of 310 postmenopausal women was studied from 1974-1981.
- Statistical analysis evaluated the impact of hysterectomy and other factors on estrogen use changes.
Main Results:
- The presence of an intact uterus was the strongest predictor for discontinuing postmenopausal estrogen use.
- Absence of a uterus was the sole strong predictor for initiating postmenopausal estrogen use.
- Women discontinuing use were older and heavier, but otherwise similar to continuers.
Conclusions:
- Fear of endometrial cancer appears to have been the main driver of reduced postmenopausal estrogen use during this period.
- Hysterectomy status was the key differentiator in postmenopausal estrogen use initiation and cessation.
- Other patient characteristics did not significantly predict initiation of postmenopausal estrogen use.